The Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

Clinical trial NCT06950645 · COMPLETED

Trial details

NCT number: NCT06950645
Sponsor: Sinovac Life Sciences Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rotavirus Gastroenteritis

Start date: 2024-03-27
Primary completion: 2024-12-21
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.